IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Endra Life Sciences Inc (NDRA)

CUSIP: 29273B500 | NYSE | Healthcare · Diagnostics & Research | Micro Cap | 17 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13DASP Isotopes Inc.254,01515.1%New 5%+ stakeOct 1, 2026No 13F filer matched
13DASP Isotopes Inc.254,015
15.1% of class · Oct 1, 2026

Institutional Holders — Q3 2026

Altium Capital Management LLC54,528
0.5% of portfolio›$325.0K
Citizens Financial Group Inc28,400
0.0% of portfolio›$169.3K
Citigroup Inc1,078
0.0% of portfolio›$6.4K
StyleTurnoverLocationFiled
Altium Capital Management LLC
54,528$325.0K0.5%YieldHighNew York, NY2026-11-04
Citizens Financial Group Inc
28,400$169.3K0.0%GrowthLowProvidence, RI2026-10-23
Citigroup Inc
1,078$6.4K0.0%CoreMediumNew York, NY2026-11-04
New 5%+ stake
No 13F filer matched